FORTUNE and Great Place to Work Name Second Genome a "Top 10 Best Workplace in Biopharma"
April 10, 2019, South San Francisco, CA
Second Genome Expands Development of CNS Platform to Validate Microbial Products as Therapeutics for Autism Spectrum Disorder
March 26, 2019, South San Francisco
Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For The Treatment Of Nonalcoholic Steatohepatitis (NASH)
January 23, 2019, South San Francisco